An Edinburgh-based biotechnology business has secured £5 million in funding to support its cutting-edge dental system and sink its teeth into the US market. Calcivis is behind patented technology that enables early detection of tooth decay - which in turn can enable timely preventive treatment – by deploying a biologic diagnostic agent in combination with an imaging device. Its latest round of investment has been led by £4m in funding from the Scottish National Investment Bank, along with £1m... Read this story
